相关实验视频

Updated: Jul 19, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.1K

针对IIb阶段初级阴道腺癌的个性化阴道应用器:一个病例报告

Saijilafu1, Yan-Jun Gu2, Ai-Wu Huang3

  • 1Hangzhou Lin'an Traditional Chinese Medicine Hospital, Affiliated Hospital, Hangzhou City University, Hangzhou 311300, Zhejiang Province, China.

World journal of clinical oncology
|August 28, 2024
PubMed
概括

这项研究突出了一个罕见的晚期阴道腺癌的罕见病例. 用于放射治疗的个人设计的阴道应用器改善了局部晚期疾病患者的瘤控制.

关键词:
在装载后进行放射治疗.案例报告案例报告主要的阴道腺癌瘤.对瘤进行控制.阴道应用器 阴道应用器

更多相关视频

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers08:13

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on: January 28, 2020

10.2K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.6K

相关概念视频

Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...